AMG
58
8
APA
37
2
VZ
37
-2
WEC
43
-2
HAS
37
-4
AVB
57
2
NSC
39
-11
SJM
21
-3
GME
57
5
AVGO
47
12
MAT
43
2
ALLE
35
-2
AAP
35
-6
L
58
3
PH
66
2
SE
63
5
IP
54
-2
ITW
58
-4
MCD
57
-5
DNB
58
-2
AMG
58
8
APA
37
2
VZ
37
-2
WEC
43
-2
HAS
37
-4
AVB
57
2
NSC
39
-11
SJM
21
-3
GME
57
5
AVGO
47
12
MAT
43
2
ALLE
35
-2
AAP
35
-6
L
58
3
PH
66
2
SE
63
5
IP
54
-2
ITW
58
-4
MCD
57
-5
DNB
58
-2
Financhill
Back

Mackenzie Emerging Markets Equity ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
24

QEE.TO
Mackenzie Emerging Markets Equity ETF

Last Price:
97.40
Seasonality Move:
-0.48%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.56
Seasonality Move:
10.65%
Sell
24
Mackenzie Emerging Markets Equity ETF (QEE.TO) is a Sell

Is Mackenzie Emerging Markets Equity ETF a Buy, Sell or Hold?

  • The current Mackenzie Emerging Markets Equity ETF [QEE.TO] share price is $97.40. The Score for QEE.TO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • QEE.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QEE.TO Stock Price Chart

What is Mackenzie Emerging Markets Equity ETF's stock price today?

  • The Mackenzie Emerging Markets Equity ETF share price today is $97.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QEE.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

QEE.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 56.81 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.33 - 97.29) Buy
Bollinger Bands (100): (92.53 - 97.51) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

QEE.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.78 Buy
20-day SMA: 95.54 Buy
50-day SMA: 96.94 Buy
200-day SMA: 92.81 Buy
8-day EMA: 96.89 Buy
20-day EMA: 96.28 Buy
50-day EMA: 96.04 Buy
200-day EMA: 92.98 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

Mackenzie Emerging Markets Equity ETF Earnings Growth & QEE.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Mackenzie Emerging Markets Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):